Literature DB >> 23494529

Effects of histamine on spontaneous neuropathic pain induced by peripheral axotomy.

Jie Yu1, Guo-Dong Lou, Jia-Xing Yue, Ying-Ying Tang, Wei-Wei Hou, Wen-Ting Shou, Hiroshi Ohtsu, Shi-Hong Zhang, Zhong Chen.   

Abstract

The present study was designed to investigate the effects of histamine on spontaneous neuropathic pain (NP) induced by peripheral axotomy. Rats and mice were subjected to complete transection of the left sciatic and saphenous nerves to induce spontaneous NP (the neuroma model). Rats were then treated with drugs once daily for 30 days (histidine and loratadine, i.p.) or 21 days (histamine, i.c.v.). Autotomy behavior was scored daily until day 50 post-operation (PO). On days 14 to 21 PO, some rats in the control group were subjected to single-fiber recording. Autotomy behavior was also monitored daily in histidine decarboxylase (the key enzyme for histamine synthesis) knockout (HDC(-/-)) and wild-type mice for 42 days. We found that both histidine (500 mg/kg) (a precursor of histamine that increases histamine levels in the tissues) and histamine (50 μg/5 μL) significantly suppressed autotomy behavior in rats. HDC(-/-) mice lacking endogenous histamine showed higher levels of autotomy than the wild-type. In addition, the analgesic effect of histidine was not antagonized by loratadine (a peripherally-acting H1 receptor antagonist), while loratadine alone significantly suppressed autotomy. Electrophysiological recording showed that ectopic spontaneous discharges from the neuroma were blocked by systemic diphenhydramine (an H1 receptor antagonist). Our results suggest that histamine plays an important role in spontaneous NP. It is likely that histamine in the central nervous system is analgesic, while in the periphery, via H1 receptors, it is algesic. This study justifies the avoidance of a histamine-rich diet and the use of peripherally-acting H1 receptor antagonists as well as agents that improve histamine action in the central nervous system in patients with spontaneous NP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494529      PMCID: PMC5561842          DOI: 10.1007/s12264-013-1316-0

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  34 in total

1.  Social variables affect phenotype in the neuroma model of neuropathic pain.

Authors:  Pnina Raber; Marshall Devor
Journal:  Pain       Date:  2002-05       Impact factor: 6.961

2.  The magnitude and duration of itch produced by intracutaneous injections of histamine.

Authors:  D A Simone; J Y Ngeow; J Whitehouse; L Becerra-Cabal; G J Putterman; R H LaMotte
Journal:  Somatosens Res       Date:  1987

3.  Neuropathic pain behavior in rats depends on the afferent input from nerve-end neuroma including histamine-sensitive C-fibers.

Authors:  Z Seltzer; Y Paran; A Eisen; R Ginzburg
Journal:  Neurosci Lett       Date:  1991-07-22       Impact factor: 3.046

4.  Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury.

Authors:  Rie Suzuki; Anthony H Dickenson
Journal:  Exp Neurol       Date:  2005-12-05       Impact factor: 5.330

5.  Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.

Authors:  A Barnett; L C Iorio; W Kreutner; S Tozzi; H S Ahn; A Gulbenkian
Journal:  Agents Actions       Date:  1984-06

6.  Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.

Authors:  Stephen J Medhurst; Sue D Collins; Andy Billinton; Sharon Bingham; Robert G Dalziel; Amanda Brass; Jennifer C Roberts; Andrew D Medhurst; Iain P Chessell
Journal:  Pain       Date:  2007-12-31       Impact factor: 6.961

7.  Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat.

Authors:  Shi-Hong Zhang; Yotam Blech-Hermoni; Laura Faravelli; Ze'ev Seltzer
Journal:  Pain       Date:  2008-06-25       Impact factor: 6.961

8.  Epidemiology and treatment of neuropathic pain: the UK primary care perspective.

Authors:  Gillian C Hall; Dawn Carroll; David Parry; Henry J McQuay
Journal:  Pain       Date:  2006-03-20       Impact factor: 6.961

9.  Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region.

Authors:  W Magerl; R A Westerman; B Möhner; H O Handwerker
Journal:  J Invest Dermatol       Date:  1990-03       Impact factor: 8.551

10.  Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells.

Authors:  Yunxia Zuo; Nicholas M Perkins; David J Tracey; Carolyn L Geczy
Journal:  Pain       Date:  2003-10       Impact factor: 6.961

View more
  10 in total

1.  SIP30 is required for neuropathic pain-evoked aversion in rats.

Authors:  Mei Han; Xiao Xiao; Yan Yang; Ru-Yi Huang; Hong Cao; Zhi-Qi Zhao; Yu-Qiu Zhang
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

2.  Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.

Authors:  Yihan Sun; Jae Hyun Kim; Kiran Vangipuram; Daniel F Hayes; Ellen M L Smith; Larisa Yeomans; N Lynn Henry; Kathleen A Stringer; Daniel L Hertz
Journal:  Breast Cancer Res Treat       Date:  2018-06-26       Impact factor: 4.872

3.  Pressure algometry and enzyme-linked immunosorbent assay of natural antibodies in the evaluation of pain syndrome.

Authors:  A I Levashova; O Yu Artiushkova; V S Morozova; S N Petrochenko; M A Myagkova; I A Moseikin; L F Panchenko
Journal:  Dokl Biochem Biophys       Date:  2016-03-31       Impact factor: 0.788

4.  Pharmacologically inhibiting GluR2 internalization alleviates neuropathic pain.

Authors:  Tao-Yan Liu; Yong Cheng; Xiao-Yan Qin; Long-Chuan Yu
Journal:  Neurosci Bull       Date:  2015-08-06       Impact factor: 5.203

5.  Gender differences in histamine-induced depolarization and inward currents in vagal ganglion neurons in rats.

Authors:  Jun-Nan Li; Zhao Qian; Wen-Xiao Xu; Bing Xu; Xiao-Long Lu; Zhen-Yu Yan; Li-Min Han; Yang Liu; Mei Yuan; John Schild; Guo-Fen Qiao; Bai-Yan Li
Journal:  Int J Biol Sci       Date:  2013-11-20       Impact factor: 6.580

Review 6.  Histamine, histamine receptors, and neuropathic pain relief.

Authors:  Ilona Obara; Vsevolod Telezhkin; Ibrahim Alrashdi; Paul L Chazot
Journal:  Br J Pharmacol       Date:  2019-06-07       Impact factor: 8.739

7.  Alterations in the gut microbiota and metabolite profiles in the context of neuropathic pain.

Authors:  Peng Chen; Chen Wang; Yan-Na Ren; Zeng-Jie Ye; Chao Jiang; Zhi-Bing Wu
Journal:  Mol Brain       Date:  2021-03-09       Impact factor: 4.041

8.  Antihistamine promotes electroacupuncture analgesia in healthy human subjects: A pilot study.

Authors:  Yu-Chen Lee; Cheng-Hao Tu; Hsin-Yi Chung; Sih-Ting Luo; Yu-Ting Chu; Iona J MacDonald; Peddanna Kotha; Chien-Chen Huang; Hsien-Yuan Lane; Jaung-Geng Lin; Yi-Hung Chen
Journal:  J Tradit Complement Med       Date:  2022-04-21

9.  Toll-like receptor 4 contributes to chronic itch, alloknesis, and spinal astrocyte activation in male mice.

Authors:  Tong Liu; Qingjian Han; Gang Chen; Ya Huang; Lin-Xia Zhao; Temugin Berta; Yong-Jing Gao; Ru-Rong Ji
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

10.  A critical time window for the analgesic effect of central histamine in the partial sciatic ligation model of neuropathic pain.

Authors:  Jie Yu; Ying-Ying Tang; Ran-Ran Wang; Guo-Dong Lou; Ting-Ting Hu; Wei-Wei Hou; Jia-Xing Yue; Hiroshi Ohtsu; Li-Yun Shi; Shi-Hong Zhang; Zhong Chen
Journal:  J Neuroinflammation       Date:  2016-06-24       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.